You are here: Home » Companies » Financial X-Ray
Pharma supply start-up Saveo Healthcare raises $4.5mn in venture round
Godi India manufactures super capacitors to improve battery life in EVs
Business Standard

Expensive deal valuations to hit Torrent Pharma's near-term earnings

Sales trajectory in domestic formulations and resolution of regulatory issues are other triggers

Topics
Torrent Pharmaceuticals | dermatology | Cosmetic Dermatology

Ram Prasad Sahu  |  Mumbai 



Torrent Pharmaceuticals
Torrent Pharmaceuticals

The stock of pharma major was down 2.5 per cent in trade as most brokerages termed its Rs 2,000 crore acquisition of Curatio, a cosmetic and paediatric company, as expensive and earnings dilutive.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, September 28 2022. 15:44 IST

RECOMMENDED FOR YOU

.